HomePEN • NYSE
add
Penumbra Inc
Previous close
$277.79
Day range
$273.03 - $280.77
Year range
$148.00 - $310.00
Market cap
10.68B USD
Avg Volume
437.88K
P/E ratio
777.26
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 315.52M | 10.83% |
Operating expense | 167.95M | 10.52% |
Net income | 33.68M | -37.87% |
Net profit margin | 10.68 | -43.94% |
Earnings per share | 0.97 | 27.63% |
EBITDA | 79.02M | 98.72% |
Effective tax rate | 24.03% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 340.13M | 17.62% |
Total assets | 1.53B | -1.49% |
Total liabilities | 382.25M | 1.30% |
Total equity | 1.15B | — |
Shares outstanding | 38.52M | — |
Price to book | 9.29 | — |
Return on assets | 12.64% | — |
Return on capital | 14.07% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 33.68M | -37.87% |
Cash from operations | 51.11M | 40.94% |
Cash from investing | -10.96M | -145.12% |
Cash from financing | 6.07M | 2.48% |
Net change in cash | 43.93M | -34.17% |
Free cash flow | 53.28M | 53.35% |
About
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. Wikipedia
Founded
2004
Website
Employees
4,500
